This inventor holds 5 USPTO granted patents. Top assignees: Akzo Nobel N.v., Akzo N.v.. Active years: 1993-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tubingen, DE (1993 - 1997)
- Tuebingen, DE (1998)
Company Filing History:
Years Active: 1993-1998
Title: Thomas C Mettenleiter: Innovator in Vaccine Development
Introduction
Thomas C Mettenleiter is a prominent inventor based in Tubingen, Germany. He has made significant contributions to the field of virology, particularly in the development of vaccines. With a total of 5 patents, his work has had a substantial impact on public health and veterinary medicine.
Latest Patents
One of his latest patents is a vaccine against viruses associated with antibody-dependent enhancement. This invention involves a herpesvirus vector capable of spreading from cell to cell, producing non-infectious progeny virions that contain a gene encoding an antigen of the targeted virus. Another notable patent is related to the preparation of a pseudorabies virus (PRV) mutant. This PRV mutant is formed by a mutation in open reading frame 1 of the BamHI fragment 4 and can be used as a vector vaccine to induce an immune response in host animals. It also allows for the differentiation between animals infected by the vaccine virus and those infected by naturally occurring viruses.
Career Highlights
Throughout his career, Thomas C Mettenleiter has worked with notable companies such as Akzo Nobel N.V. and Akzo N.V. His expertise in vaccine development has positioned him as a key figure in the field of virology.
Collaborations
He has collaborated with esteemed colleagues, including Nicolaas Visser and Christa S Schreurs, contributing to advancements in vaccine research and development.
Conclusion
Thomas C Mettenleiter's innovative work in vaccine development has made a lasting impact on both human and animal health. His contributions continue to shape the future of virology and immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

